Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127603071 | 12760307 | 1 | I | 2016 | 20160907 | 20160919 | 20160919 | EXP | US-TEVA-692454USA | TEVA | 0.00 | M | Y | 140.74000 | KG | 20160919 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127603071 | 12760307 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | UNKNOWN FORM STRENGTH | U | 20622 | |||||||||
| 127603071 | 12760307 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 20 MILLIGRAM DAILY; | 0000079859 | 0 | 10 | MG | TABLET | BID | |||||
| 127603071 | 12760307 | 3 | SS | TECFIDERA | DIMETHYL FUMARATE | 1 | Oral | U | 0 | ||||||||||
| 127603071 | 12760307 | 4 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | U | 0 | ||||||||||
| 127603071 | 12760307 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 6 | C | BACLOFEN. | BACLOFEN | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 7 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 8 | C | DULOXETINE. | DULOXETINE | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 10 | C | MUCINEX | GUAIFENESIN | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 12 | C | Vitamin b | VITAMIN B | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 13 | C | Magnesium | MAGNESIUM | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 14 | C | Fish oil | FISH OIL | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 15 | C | Probiotic | PROBIOTICS NOS | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 16 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 127603071 | 12760307 | 17 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127603071 | 12760307 | 1 | Multiple sclerosis |
| 127603071 | 12760307 | 2 | Gait disturbance |
| 127603071 | 12760307 | 3 | Multiple sclerosis |
| 127603071 | 12760307 | 4 | Sleep disorder |
| 127603071 | 12760307 | 17 | Sleep disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127603071 | 12760307 | OT |
| 127603071 | 12760307 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127603071 | 12760307 | Insomnia | |
| 127603071 | 12760307 | Lung disorder | |
| 127603071 | 12760307 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127603071 | 12760307 | 1 | 2016 | 0 | ||
| 127603071 | 12760307 | 2 | 2014 | 0 | ||
| 127603071 | 12760307 | 3 | 2016 | 0 |